ECG Sensor Patch Market to Partake Significant Development By 2026

ECG sensor patch is a diagnostic tool used by the clinicians for early detection of atrial fibrillation and to ensure timely treatment for such patients. The wearable patch continuously record the ECG of user, which aids in arrhythmia detection and management at the point of care. It also acts as triggering alarm for the cardiac patient about the stress levels and thus increasing the patient compliance.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/2832

Market Dynamics

Increasing product launches by market players is a major factor driving global ECG sensor patch market growth. For instance, in January 2019, Lief Therapeutics launched a newly developed smart patch at the Consumer Electronics Show. The patch allows users to easily detect, manage, and treat stress in real-time using haptic biofeedback technology.

Furthermore, inorganic strategies adopted by key players for enhancing their distribution network and offering best products in the market is expected to drive the market growth. For instance, in November 2018, Cardiac Insight, Inc. collaborated with VivoSense to deliver enhanced analytics to expand use of wearable cardiac sensors in clinical trials and other healthcare applications. Similarly, in November 2018, AliveCor, Inc. and C. ILLIES & CO., a distribution partner for technology innovators in Asia, entered into new distribution agreement to launch AliveCor Mobile ECG in Hong Kong and Macau.

Key Players:

Key companies covered as a part of this study include Medtronic Plc., Hill-Rome Holdings, Inc., iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., and Lief Therapeutics

Detailed Segmentation:

Global ECG Sensor Patch Market, By Product Type:
Hardware
Software

Global ECG Sensor Patch Market, By Application:
Monitoring
Diagnostics

Global ECG Sensor Patch Market, By End User:
Healthcare
Fitness and Sports

Global ECG Sensor Patch Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Technological advancements in ECG sensor patch and new product launch is expected to propel the market growth

Market players are focused on technological advancement and product launch in the potential market, which is expected to drive the global ECG sensor patch market. For instance, in 2016, VitalConnect launched the VitalPatch biosensor at the 2016 HIMSS Conference. The lightweight, wireless patch continuously monitors and records single lead ECG, heart rate, variability, respiratory rate, and other parameters with clinical accuracy.

Increasing focus of researchers on monitoring various body parameters is expected to augment the market growth over the forecast period. For instance, in 2016, engineers at the University of California, San Diego developed the first flexible wearable device that records ECG heart signals and tracks levels of lactate, a biochemical that is a marker of physical effort, in real time.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2832

Increasing prevalence of Atrial Fibrillation in North America is expected to bolster the market growth

North America holds dominant position in the global ECG sensor patch market over the forecast period, owing to increasing prevalence of atrial fibrillation and other cardiac conditions. According to American Heart Association, in 2016, stroke was a leading cause of death in the U.S. with around 2.7 million people in the country living with atrial fibrillation and around 800,000 suffering from a stroke, annually. It was due to block or bursts in the blood vessel that supplies blood to the brain. Therefore, increasing prevalence of atrial fibrillation boosts growth of the global ECG sensor patch market.

Increasing product launches and product approval in the region is the major factor expected to propel the market growth. For instance, in 2017, Cardiac Insight launched Cardea Solo ECG sensor designed for diagnosing atrial fibrillation following cardiac ablation after receiving the U.S. Food and Drugs Administration (FDA) 510 (k) clearance.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com